Products > IHC > Antibodies for immunohistochemistry

Antibodies for immunohistochemistry

Reach out to the antigen

In addition to the well-known own brand Zytomed Systems, the current program includes tried and tested reagents from Diagnostic Biosystems, BioCare Medical, Zeta Corporation among others. We are constantly testing new antibodies and detection systems to meet the specific requirements of the laboratories and scientific users in the best possible way. Most of the primary antibodies are available both as concentrates and as ready-to-use products.

Sorry, no results could be found for your request.
Products may not be approved or available in your region. Please check with your local Zytomed-Systems representative.
Product Clone Order no.
Host Mouse
Clone IVT-2000
Format Concentrate
Method P
Pretreatment Citrate or Fast Enzyme
Dilution 1:100 - 1:200
Isotype Mouse IgG
Localization Cytoplasm
Cytokeratin 8 & 18 		IVT-2000 MSK035-05
Host Mouse
Clone 5D3
Format Ready-to-use
Method F, P
Pretreatment Pepsin or Trypsin
Positive control Skin
Dilution -
Isotype Mouse IgG1
Localization Cytoplasm
Cytokeratin 8 & 18 		5D3 PDM070
Host Mouse
Clone B22.1/B23.1
Format Concentrate
Reactivity -
Method P
Positive control Skin, breast carcinoma.
Dilution 1:100 - 1:200
Isotype IgG1 /κ + IgG1 /κ
Immunogen Cytokeratins purified from breast cancer MCF-7 cells
Localization Cytoplasm
Cytokeratin 8/18 		B22.1/B23.1 Z2252ML
Host Mouse
Clone B22.1/B23.1
Format Ready-to-use
Reactivity -
Method P
Positive control Skin, breast carcinoma.
Dilution -
Isotype IgG1 /κ + IgG1 /κ
Immunogen Cytokeratins purified from breast cancer MCF-7 cells
Localization Cytoplasm
Cytokeratin 8/18 		B22.1/B23.1 Z2252MP
Host Mouse
Clone B22.1/B23.1
Format Concentrate
Reactivity -
Method P
Positive control Skin, breast carcinoma.
Dilution 1:100 - 1:200
Isotype IgG1 /κ + IgG1 /κ
Immunogen Cytokeratins purified from breast cancer MCF-7 cells
Localization Cytoplasm
Cytokeratin 8/18 		B22.1/B23.1 Z2252MS
Host Mouse
Clone B22.1/B23.1
Format Concentrate
Reactivity -
Method P
Positive control Skin, breast carcinoma.
Dilution 1:100 - 1:200
Isotype IgG1 /κ + IgG1 /κ
Immunogen Cytokeratins purified from breast cancer MCF-7 cells
Localization Cytoplasm
Cytokeratin 8/18 		B22.1/B23.1 Z2252MT
Host Mouse
Clone ZM125
Format Concentrate
Reactivity -
Method P
Positive control Skin, breast carcinoma.
Dilution 1:100 - 1:200
Isotype IgG1 /κ
Immunogen Cytoskeleton preparation from HeLa cells
Localization Cytoplasm
Cytokeratin 8/18 		ZM125 Z2435ML
Host Mouse
Clone ZM125
Format Ready-to-use
Reactivity -
Method P
Positive control Skin, breast carcinoma.
Dilution -
Isotype IgG1 /κ
Immunogen Cytoskeleton preparation from HeLa cells
Localization Cytoplasm
Cytokeratin 8/18 		ZM125 Z2435MP
Host Mouse
Clone ZM125
Format Concentrate
Reactivity -
Method P
Positive control Skin, breast carcinoma.
Dilution 1:100 - 1:200
Isotype IgG1 /κ
Immunogen Cytoskeleton preparation from HeLa cells
Localization Cytoplasm
Cytokeratin 8/18 		ZM125 Z2435MS
Host Mouse
Clone ZM125
Format Concentrate
Reactivity -
Method P
Positive control Skin, breast carcinoma.
Dilution 1:100 - 1:200
Isotype IgG1 /κ
Immunogen Cytoskeleton preparation from HeLa cells
Localization Cytoplasm
Cytokeratin 8/18 		ZM125 Z2435MT
Host Mouse
Clone Ks-1A3
Format Concentrate
Method F, P
Pretreatment Citrate
Positive control Skin
Dilution 1:25 - 1:100
Isotype Mouse IgG
Localization Cytoplasm
Cytokeratin 13 		Ks-1A3 MOB443
Host Mouse
Clone Ks-1A3
Format Concentrate
Method F, P
Pretreatment Citrate
Positive control Skin
Dilution 1:25 - 1:100
Isotype Mouse IgG
Localization Cytoplasm
Cytokeratin 13 		Ks-1A3 MOB443-01
Host Mouse
Clone Ks-1A3
Format Concentrate
Method F, P
Pretreatment Citrate
Positive control Skin
Dilution 1:25 - 1:100
Isotype Mouse IgG
Localization Cytoplasm
Cytokeratin 13 		Ks-1A3 MOB443-05
Host Mouse
Clone LL002
Format Purified
Method F, P
Pretreatment Citrate
Positive control Skin
Isotype Mouse IgG3
Immunogen Last 15 C-terminal residues of human Cytokeratin 14 conjugated to Thyroglobulin
Cytokeratin 14 		LL002 601-2167
Host Mouse
Clone LL002
Format Concentrate
Method F, P
Pretreatment Citrate
Positive control Skin
Dilution 1:25 - 1:75
Isotype Mouse IgG3
Localization Cytoplasm
Cytokeratin 14 		LL002 MOB186
Host Mouse
Clone LL002
Format Concentrate
Method F, P
Pretreatment Citrate
Positive control Skin
Dilution 1:25 - 1:75
Isotype Mouse IgG3
Localization Cytoplasm
Cytokeratin 14 		LL002 MOB186-01
Host Mouse
Clone LL002
Format Concentrate
Method F, P
Pretreatment Citrate
Positive control Skin
Dilution 1:25 - 1:75
Isotype Mouse IgG3
Localization Cytoplasm
Cytokeratin 14 		LL002 MOB186-05
Host Mouse
Clone LL002
Format Ready-to-use
Method F, P
Pretreatment Citrate
Positive control Skin
Dilution -
Isotype Mouse IgG3
Localization Cytoplasm
Cytokeratin 14 		LL002 PDM138
Host Mouse
Clone LL002
Format Concentrate
Reactivity -
Method P
Positive control Skin, tonsil or squamous cell carcinoma.
Dilution 1:100 - 1:300
Isotype IgG3 /κ
Immunogen A synthetic peptide of 15 amino acid residues from the C-terminus of human keratin 14
Localization Cytoplasm
Cytokeratin 14 		LL002 Z2042ML
Host Mouse
Clone LL002
Format Ready-to-use
Reactivity -
Method P
Positive control Skin, tonsil or squamous cell carcinoma.
Dilution -
Isotype IgG3 /κ
Immunogen A synthetic peptide of 15 amino acid residues from the C-terminus of human keratin 14
Localization Cytoplasm
Cytokeratin 14 		LL002 Z2042MP
Host Mouse
Clone LL002
Format Concentrate
Reactivity -
Method P
Positive control Skin, tonsil or squamous cell carcinoma.
Dilution 1:100 - 1:300
Isotype IgG3 /κ
Immunogen A synthetic peptide of 15 amino acid residues from the C-terminus of human keratin 14
Localization Cytoplasm
Cytokeratin 14 		LL002 Z2042MS
Host Mouse
Clone LL002
Format Concentrate
Reactivity -
Method P
Positive control Skin, tonsil or squamous cell carcinoma.
Dilution 1:100 - 1:300
Isotype IgG3 /κ
Immunogen A synthetic peptide of 15 amino acid residues from the C-terminus of human keratin 14
Localization Cytoplasm
Cytokeratin 14 		LL002 Z2042MT
Host Mouse
Clone LHK15
Format Concentrate
Method F, P
Pretreatment Citrate
Positive control Skin
Dilution 1:25 - 1:75
Isotype Mouse IgG2a
Localization Cytoplasm
Cytokeratin 15 		LHK15 MOB305
Host Mouse
Clone LHK15
Format Concentrate
Method F, P
Pretreatment Citrate
Positive control Skin
Dilution 1:25 - 1:75
Isotype Mouse IgG2a
Localization Cytoplasm
Cytokeratin 15 		LHK15 MOB305-01
Host Mouse
Clone LHK15
Format Concentrate
Method F, P
Pretreatment Citrate
Positive control Skin
Dilution 1:25 - 1:75
Isotype Mouse IgG2a
Localization Cytoplasm
Cytokeratin 15 		LHK15 MOB305-05
Host Mouse
Clone LL025
Format Concentrate
Method F, P
Pretreatment Citrate
Positive control Skin
Dilution 1:25 - 1:75
Isotype Mouse IgG1
Localization Cytoplasm
Cytokeratin 16 		LL025 MOB273
Host Mouse
Clone LL025
Format Concentrate
Method F, P
Pretreatment Citrate
Positive control Skin
Dilution 1:25 - 1:75
Isotype Mouse IgG1
Localization Cytoplasm
Cytokeratin 16 		LL025 MOB273-01
Host Mouse
Clone LL025
Format Concentrate
Method F, P
Pretreatment Citrate
Positive control Skin
Dilution 1:25 - 1:75
Isotype Mouse IgG1
Localization Cytoplasm
Cytokeratin 16 		LL025 MOB273-05
Host Mouse
Clone E3
Format Concentrate
Method F, P
Pretreatment Citrate
Positive control Skin
Dilution 1:25 - 1:50
Isotype Mouse IgG2b
Localization Cytoplasm
Cytokeratin 17 		E3 MOB127
Host Mouse
Clone E3
Format Concentrate
Method F, P
Pretreatment Citrate
Positive control Skin
Dilution 1:25 - 1:50
Isotype Mouse IgG2b
Localization Cytoplasm
Cytokeratin 17 		E3 MOB127-01
Host Mouse
Clone E3
Format Concentrate
Method F, P
Pretreatment Citrate
Positive control Skin
Dilution 1:25 - 1:50
Isotype Mouse IgG2b
Localization Cytoplasm
Cytokeratin 17 		E3 MOB127-05
Host Mouse
Clone E3
Format ready-to-use
Method F, P
Pretreatment Citrate
Positive control Skin
Dilution ---
Isotype Mouse IgG2b
Localization Cytoplasm
Cytokeratin 17 		E3 PDM206
Host Mouse
Clone E3
Format Concentrate
Reactivity -
Method P
Positive control Squamous cell carcinoma or skin.
Dilution 1:100 - 1:200
Isotype IgG2b /κ
Immunogen Keratin purified from rat enterocytes
Localization Cytoplasm
Cytokeratin 17 		E3 Z2254ML
Host Mouse
Clone E3
Format Ready-to-use
Reactivity -
Method P
Positive control Squamous cell carcinoma or skin.
Dilution -
Isotype IgG2b /κ
Immunogen Keratin purified from rat enterocytes
Localization Cytoplasm
Cytokeratin 17 		E3 Z2254MP
Host Mouse
Clone E3
Format Concentrate
Reactivity -
Method P
Positive control Squamous cell carcinoma or skin.
Dilution 1:100 - 1:200
Isotype IgG2b /κ
Immunogen Keratin purified from rat enterocytes
Localization Cytoplasm
Cytokeratin 17 		E3 Z2254MS
Host Mouse
Clone E3
Format Concentrate
Reactivity -
Method P
Positive control Squamous cell carcinoma or skin.
Dilution 1:100 - 1:200
Isotype IgG2b /κ
Immunogen Keratin purified from rat enterocytes
Localization Cytoplasm
Cytokeratin 17 		E3 Z2254MT
Host Mouse
Clone DC10
Format Concentrate
Method P, WB
Pretreatment Citrate
Positive control Breast Carcinoma, Skin
Dilution 1:100
Isotype Mouse IgG1
Immunogen Human breast cancer PMC42 cells
Localization Cytoplasm
Cytokeratin 18 		DC10 503-17012
Host Mouse
Clone DC10
Format Concentrate
Method P, WB
Pretreatment Citrate
Positive control Breast Carcinoma, Skin
Dilution 1:100
Isotype Mouse IgG1
Immunogen Human breast cancer PMC42 cells
Localization Cytoplasm
Cytokeratin 18 		DC10 503-17014
Host Mouse
Clone DC10
Format Concentrate
Method P
Pretreatment Citrate
Dilution 1:50 - 1:200
Isotype IgG1
Localization Cytoplasm
Cytokeratin 18 		DC10 MOB187
Host Mouse
Clone DC-10
Format Ready-to-use
Method F, P
Pretreatment Citrate or Fast Enzyme
Dilution -
Isotype Mouse IgG1
Localization Cytoplasm
Cytokeratin 18 		DC-10 MSG016
Host Mouse
Clone DC-10
Format Concentrate
Method F, P
Pretreatment Citrate or Fast Enzyme
Dilution 1:100 - 1:200
Isotype Mouse IgG1
Localization Cytoplasm
Cytokeratin 18 		DC-10 MSK016
Host Mouse
Clone DC-10
Format Concentrate
Method F, P
Pretreatment Citrate or Fast Enzyme
Dilution 1:100 - 1:200
Isotype Mouse IgG1
Localization Cytoplasm
Cytokeratin 18 		DC-10 MSK016-05
Host Mouse
Clone DC10
Format Concentrate
Reactivity -
Method P
Positive control Breast carcinoma.
Dilution 1:100 - 1:200
Isotype IgG1 /κ
Immunogen Human breast cancer PMC 42 cells
Localization Cytoplasm
Cytokeratin 18 		DC10 Z2044ML
Host Mouse
Clone DC10
Format Ready-to-use
Reactivity -
Method P
Positive control Breast carcinoma.
Dilution -
Isotype IgG1 /κ
Immunogen Human breast cancer PMC 42 cells
Localization Cytoplasm
Cytokeratin 18 		DC10 Z2044MP
Host Mouse
Clone DC10
Format Concentrate
Reactivity -
Method P
Positive control Breast carcinoma.
Dilution 1:100 - 1:200
Isotype IgG1 /κ
Immunogen Human breast cancer PMC 42 cells
Localization Cytoplasm
Cytokeratin 18 		DC10 Z2044MS
Host Mouse
Clone DC10
Format Concentrate
Reactivity -
Method P
Positive control Breast carcinoma.
Dilution 1:100 - 1:200
Isotype IgG1 /κ
Immunogen Human breast cancer PMC 42 cells
Localization Cytoplasm
Cytokeratin 18 		DC10 Z2044MT
Host Mouse
Clone ZM205
Format Concentrate
Reactivity -
Method P
Positive control Breast carcinoma.
Dilution 1:100 - 1:200
Isotype IgG1 /κ
Immunogen Recombinant human KRT18 protein
Localization Cytoplasm
Cytokeratin 18 		ZM205 Z2541ML
Host Mouse
Clone ZM205
Format Ready-to-use
Reactivity -
Method P
Positive control Breast carcinoma.
Dilution -
Isotype IgG1 /κ
Immunogen Recombinant human KRT18 protein
Localization Cytoplasm
Cytokeratin 18 		ZM205 Z2541MP
Host Mouse
Clone ZM205
Format Concentrate
Reactivity -
Method P
Positive control Breast carcinoma.
Dilution 1:100 - 1:200
Isotype IgG1 /κ
Immunogen Recombinant human KRT18 protein
Localization Cytoplasm
Cytokeratin 18 		ZM205 Z2541MS
Host Mouse
Clone ZM205
Format Concentrate
Reactivity -
Method P
Positive control Breast carcinoma.
Dilution 1:100 - 1:200
Isotype IgG1 /κ
Immunogen Recombinant human KRT18 protein
Localization Cytoplasm
Cytokeratin 18 		ZM205 Z2541MT
< Page 21 of 65 >
Products may not be approved or available in your region. Please check with your local Zytomed-Systems representative.
Product Clone Order no.
Load more

Key to the method:

EL = ELISA; F = Frozen section IHC; FL = Flow Cytometry; IF = Immunfluoreszenz; IP = Immunoprecipitation; P = Paraffin section IHC; WB = Western Blot; u. a. = and others

Products

Topics

Learning videos

Downloads

Company

Distributors

Privacy Imprint
DE EN

Product availability

Products may not be approved or available in your region. Please check with your local Zytomed-Systems representative.

Got it